Psyence Biomedical Ltd.
13F holders, Q1 2025 (March 31)8holders −3
4new positions
7sold out
1famous investor
$0.60avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Psyence Biomedical Ltd. in their 13F filings, down 3 from Q4 2024. 4 opened new positions and 7 sold out. The largest holders were Sabby Management, LLC ($154K), Citadel Advisors ($45K) and Virtu Financial LLC ($22K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F209
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $165K |
| Exits | 7 | $1.4M |
All 13F filers, Q4 2024 → Q1 2025: 391,189 shares bought and 686,053 shares sold, net −294,864 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Sabby Management, LLC | 0.65% | New | 256,700 | $154K |
| Citadel Advisors | 0.00% | Add +555.5% | 75,318 | $45K |
| Virtu Financial LLC | 0.00% | Add +187.4% | 36,482 | $22K |
| AdvisorShares Investments LLC | 0.00% | Add +31.7% | 35,458 | $21K |
| UBS Group AG | 0.00% | Add +164.0% | 33,559 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 12,941 | $8K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | New | 4,479 | $3K |
| Morgan Stanley | 0.00% | New | 69 | $41 |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.